12:00 AM
May 19, 2014
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AV4025: Phase Ib started

AllaChem began a double-blind, placebo-controlled, Russian Phase Ib trial to evaluate 20 or 40 mg oral AV4025 once daily...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >